Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

SNC PHARMACIE NOTRE DAME DE KERELLON : revenue, balance sheet and financial ratios

SNC PHARMACIE NOTRE DAME DE KERELLON is a French company founded 39 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in PLOUENAN (29420), this company of category PME shows in 2025 a net income positive of 155 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-09

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - SNC PHARMACIE NOTRE DAME DE KERELLON (SIREN 341835890)
Indicator 2025 2024 2023 2022
Revenue N/C N/C N/C N/C
Net income 154 848 € 164 619 € 210 413 € 257 377 €
EBITDA N/C N/C N/C N/C
Net margin N/C N/C N/C N/C

Revenue and income statement

In 2025, SNC PHARMACIE NOTRE DAME DE KERELLON generates positive net income of 155 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2022-2025: 257 k€ -> 155 k€.

Net income (2025) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

154 848 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 100%. Debt level is high: negotiating margin with banks is reduced. Financial autonomy (= Equity / Total assets x 100) reaches 40%. This high autonomy means the company finances most of its assets through equity, a sign of strength.

Debt ratio (2025) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

100.021%

Financial autonomy (2025) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

40.053%

Asset age ratio (2025) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

6.5%

Solvency indicators evolution
SNC PHARMACIE NOTRE DAME DE KERELLON

Sector positioning

Debt ratio
100.02 2025
2023
2024
2025
Q1: 13.7
Med: 49.79
Q3: 129.09
Average -9 pts over 3 years

In 2025, the debt ratio of SNC PHARMACIE NOTRE DAME ... (100.02) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.

Financial autonomy
40.05% 2025
2023
2024
2025
Q1: 33.42%
Med: 53.72%
Q3: 72.08%
Average +7 pts over 3 years

In 2025, the financial autonomy of SNC PHARMACIE NOTRE DAME ... (40.0%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 216.59. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2025) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

216.585

Liquidity indicators evolution
SNC PHARMACIE NOTRE DAME DE KERELLON

Sector positioning

Liquidity ratio
216.59 2025
2023
2024
2025
Q1: 131.03
Med: 182.25
Q3: 258.64
Good -14 pts over 3 years

In 2025, the liquidity ratio of SNC PHARMACIE NOTRE DAME ... (216.59) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.

Positioning of SNC PHARMACIE NOTRE DAME DE KERELLON in its sector

Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé

Valuation estimate

Based on 277 transactions of similar company sales in 2025, the value of SNC PHARMACIE NOTRE DAME DE KERELLON is estimated at 2 459 778 € (range 1 669 217€ - 3 859 731€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2025
277 transactions
1669k€ 2459k€ 3859k€
2 459 778 € Range: 1 669 217€ - 3 859 731€
NAF 5 année 2025

Valuation method used

Net Income Multiple
154 848 € × 15.9x = 2 459 779 €
Range: 1 669 218€ - 3 859 732€

Only this financial indicator is available for this company.

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare SNC PHARMACIE NOTRE DAME DE KERELLON with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de détail de produits pharmaceutiques en magasin spécialisé

Frequently asked questions about SNC PHARMACIE NOTRE DAME DE KERELLON

What is the revenue of SNC PHARMACIE NOTRE DAME DE KERELLON ?

The revenue of SNC PHARMACIE NOTRE DAME DE KERELLON is not publicly disclosed (confidential accounts filed with INPI).

Is SNC PHARMACIE NOTRE DAME DE KERELLON profitable?

Yes, SNC PHARMACIE NOTRE DAME DE KERELLON generated a net profit of 155 k€ in 2025.

Where is the headquarters of SNC PHARMACIE NOTRE DAME DE KERELLON ?

The headquarters of SNC PHARMACIE NOTRE DAME DE KERELLON is located in PLOUENAN (29420), in the department Finistere.

Where to find the tax return of SNC PHARMACIE NOTRE DAME DE KERELLON ?

The tax return of SNC PHARMACIE NOTRE DAME DE KERELLON is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does SNC PHARMACIE NOTRE DAME DE KERELLON operate?

SNC PHARMACIE NOTRE DAME DE KERELLON operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.